Supreme Court to Hear Bayer's Roundup Lawsuit Appeal

The U.S. Supreme Court will hear Bayer's appeal aiming to limit lawsuits claiming its Roundup weedkiller causes cancer. Bayer seeks to avoid billions in damages through this legal strategy, arguing federal law should preclude state law claims. The outcome could impact numerous pending lawsuits.

The U.S. Supreme Court has agreed to hear Bayer's appeal in a legal battle over allegations that its Roundup weedkiller causes cancer. The decision could potentially shield the company from billions of dollars in damages.

In a case brought by John Durnell, who claimed Roundup exposure led to his non-Hodgkin's lymphoma diagnosis, the Missouri Court of Appeals had previously upheld a $1.25 million verdict against Bayer. The company contends that federal law should protect it from such state-level lawsuits, given the EPA's findings that Roundup is not carcinogenic.

Bayer aims to leverage this Supreme Court hearing as part of its broader strategy to manage over 65,000 similar claims. The result could determine the future of these lawsuits. The company has already paid around $10 billion in settlements but continues to face new cases.

(With inputs from agencies.)